Transfection: introduction of nucleic acids into cells

Key characteristics and mechanisms

Transfected nucleic acids can take several forms: plasmid DNA that expresses a protein, messenger RNA (mRNA) that is translated directly, or small interfering RNA (siRNA) that induces gene silencing. Delivery may be transient, with effects lasting only hours to days (common for RNA), or stable, when DNA integrates into the host genome or persists episomally, producing long-term expression. Outcomes depend on the molecule, the host cell type and the method of delivery.

Common methods

Researchers choose from chemical, physical and biological approaches. Common techniques include:

• Cationic lipids or lipid nanoparticles that encapsulate nucleic acids and fuse with cell membranes.
• Polymeric or calcium phosphate reagents that facilitate uptake across the membrane.
• Electroporation, which uses short electrical pulses to open pores in cell membranes.
• Microinjection or biolistic (gene gun) approaches for direct delivery, important for single cells or tissues such as embryos.
• Viral vectors derived from a virus used as a vector to carry genetic material into cells.

History and development

Transfection emerged as a distinct laboratory practice in the mid-20th century as scientists developed methods for introducing nucleic acids into cultured cells (tissue culture) and prokaryotes. Early protein expression and cloning work relied on chemical methods and bacteriophage or plasmid-mediated transformation; later, more efficient lipid-based reagents and electroporation expanded capability. The advent of engineered viral vectors and nanoparticle technologies further broadened applications.

Applications and examples

Transfection is foundational in molecular biology and biomedical research. Typical uses include creating cells that express a reporter protein, delivering templates for gene editing (for example when using CRISPR systems), testing gene function by overexpression or knockdown, and producing recombinant proteins. In clinical contexts, related delivery strategies underpin some approaches to gene therapy and to mRNA-based vaccines or therapeutics.

Limitations, risks and distinctions

Effects of transfection can be unpredictable: some methods induce stress responses, altered morphology, or changes in growth. RNA-based transfections generally do not produce permanent genetic change because RNA is not incorporated into the nucleus; DNA transfections can lead to stable modification if integration occurs. Viral vectors offer high efficiency but raise safety considerations and immune responses. Careful selection of method, controls and validation is essential when interpreting experimental results or designing therapeutic strategies.